MONTEREY, Calif. — Interferon alpha-2b, 5-fluorouracil and mitomycin C can all be used topically for conjunctival tumors, Lauren A. Dalvin, MD, said at the Women in Ophthalmology Summer Symposium.
“Compared to surgical therapy, these do require more time; these do require reliable patient follow-up,” Dalvin said.
The medications can be used effectively as primary tumor treatment, chemoreduction before surgery or adjuvant therapy after surgery; however, insurance coverage can be challenging, she said.
“Interferon has always been my favorite because it is really well tolerated,”